FDA Approves First Generic Once-Weekly Hormone Therapy Patch
The FDA approved the first generic of Climara Pro, an estradiol and levonorgestrel transdermal hormone therapy patch applied once weekly.
The FDA approved the first generic of Climara Pro, an estradiol and levonorgestrel transdermal hormone therapy patch applied once weekly.